Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
TGF-beta regulation of extracellular matrix	27/565	5.269659595648581E-11	2.4556613715722388E-8	0	0	5.2796635992443175	124.95100152962983	ADH1B;THBS2;HERPUD1;ADAMTS1;CTSK;TIMP3;STOM;A2M;CD34;S100A10;KLF10;BRD2;POSTN;PLK2;CAV1;F2R;FN1;FMO2;DKK1;TM4SF1;AGT;APLN;COL1A1;ACTA2;COL1A2;COL4A2;ATF3
Collagen biosynthesis and modifying enzymes	10/64	1.214849991175935E-9	2.8306004794399287E-7	0	0	18.274074074074075	375.1419836068297	COL1A1;ADAMTS2;COL3A1;COL1A2;COL4A2;COL4A1;COL5A2;COL6A3;COL8A1;PCOLCE
Integrins in angiogenesis	10/74	5.259770365559602E-9	8.170176634502582E-7	0	0	15.4109375	293.7814519199599	COL1A1;COL3A1;COL1A2;RPS6KB1;COL4A1;COL5A2;FN1;COL6A3;COL8A1;F11R
BDNF signaling pathway	16/261	1.7816950345450622E-8	2.0756747152449977E-6	0	0	6.579423521986114	117.39741426156378	KLF10;HSPA5;GDF15;PLK2;DKK1;GNG11;CLU;HERPUD1;UGDH;ABLIM1;ZEB1;MGP;SRSF5;ATF3;EIF4B;S100A10
Platelet activation, signaling and aggregation	14/205	3.717645964214317E-8	3.4648460386477432E-6	0	0	7.329468960359013	125.38955048737424	SPARC;HSPA5;F2R;FN1;GNG11;CLU;VAV2;COL1A1;COL1A2;CALU;PECAM1;SERPING1;A2M;F2RL3
Extracellular matrix organization	10/93	4.974972435539902E-8	3.863895258269324E-6	0	0	11.871686746987951	199.63738182605726	COL1A1;ADAMTS2;COL3A1;COL1A2;COL4A2;COL4A1;COL5A2;COL6A3;COL8A1;PCOLCE
Hemostasis pathway	20/468	1.2091158687881603E-7	8.049257069361182E-6	0	0	4.544642857142857	72.38800874018003	SPARC;CBX5;HSPA5;CAV1;F2R;FN1;SLC3A2;F11R;GNG11;CLU;PHF21A;VAV2;COL1A1;COL1A2;KIF5B;CALU;PECAM1;SERPING1;A2M;F2RL3
ECM-receptor interaction	9/84	2.434641768461209E-7	1.4181788301286542E-5	0	0	11.770149253731343	179.23931706979187	COL1A1;COL3A1;COL1A2;COL4A2;COL4A1;COL5A2;FN1;COL6A3;THBS2
Beta-3 integrin cell surface interactions	7/43	2.976819140705345E-7	1.5413307995207676E-5	0	0	18.921455938697317	284.33726565126557	COL1A1;COL1A2;COL4A1;FN1;PECAM1;THY1;F11R
NCAM1 interactions	7/44	3.5086744553229627E-7	1.6350422961805006E-5	0	0	18.409133271202236	273.6123214315527	COL1A1;COL3A1;COL1A2;COL4A2;COL4A1;COL5A2;COL6A3
Beta-1 integrin cell surface interactions	8/66	4.4041686394882823E-7	1.865765987274127E-5	0	0	13.473540457494025	197.19259609427525	COL1A1;COL3A1;COL1A2;COL4A1;COL5A2;FN1;COL6A3;THBS2
Syndecan 1 pathway	7/46	4.814439217323397E-7	1.8696072293939195E-5	0	0	17.463306808134394	254.02957473183602	COL1A1;COL3A1;COL1A2;COL4A1;COL5A2;COL6A3;COL8A1
Response to elevated platelet cytosolic calcium	8/83	2.596479813787448E-6	9.307381486345775E-5	0	0	10.41056105610561	133.89391054073104	SPARC;HSPA5;PECAM1;FN1;CALU;SERPING1;A2M;CLU
NCAM signaling for neurite out-growth	7/70	8.714067823445561E-6	2.900539718375451E-4	0	0	10.797482211275314	125.79684226944585	COL1A1;COL3A1;COL1A2;COL4A2;COL4A1;COL5A2;COL6A3
Prothrombin activation intrinsic pathway	5/32	1.945242937088243E-5	6.043221391220807E-4	0	0	17.85275519421861	193.65845094839068	COL4A2;COL4A1;F2R;SERPING1;A2M
FSH regulation of apoptosis	12/263	2.3211523174037494E-5	6.76035612443842E-4	0	0	4.717855849329953	50.34358735509182	KLF10;PTP4A1;ACTA2;ABLIM1;GPRC5A;ZEB1;TIMP3;PMAIP1;THY1;DKK1;CLU;ACTG2
Integrin cell surface interactions	7/85	3.1416122676387114E-5	8.611713627762585E-4	0	0	8.714412024756852	90.35267382280456	COL1A1;COL1A2;COL4A2;COL4A1;PECAM1;FN1;F11R
Focal adhesion	11/233	3.7397187816415985E-5	9.681716401361027E-4	0	0	4.872289374801937	49.66770397817358	COL1A1;COL3A1;COL1A2;COL4A2;COL4A1;CAV1;COL5A2;FN1;COL6A3;THBS2;VAV2
Signaling by PDGF	8/122	4.4700661946180245E-5	0.001096342550890526	0	0	6.835504603091888	68.46114842730877	COL1A1;COL3A1;COL1A2;COL4A2;COL4A1;COL5A2;COL6A3;THBS2
Cell surface interactions at the vascular wall	7/94	6.016567553388073E-5	0.001401860239939421	0	0	7.809353943717796	75.89449207503608	COL1A1;COL1A2;CAV1;PECAM1;FN1;SLC3A2;F11R
Oncostatin M	12/311	1.1647187432098131E-4	0.002571440684570044	0	0	3.9507449072666465	35.78529717444268	COL1A1;KLF10;ZHX2;COL1A2;HSPA5;KIF5B;F2R;FN1;PCOLCE;VIM;ATF3;SYNE1
Amoebiasis	7/105	1.2139848725437974E-4	0.002571440684570044	0	0	6.9289232934553135	62.4741666804622	COL1A1;COL3A1;COL1A2;COL4A2;COL4A1;COL5A2;FN1
Muscle contraction	5/49	1.5937509376320568E-4	0.003229077986680602	0	0	10.945676274944567	95.71173035533467	ACTA2;CALD1;TNNT2;VIM;ACTG2
Inflammatory response pathway	4/30	2.613008244599698E-4	0.005073591008264414	0	0	14.760268857356236	121.7698303077272	COL1A1;COL3A1;COL1A2;FN1
Angiotensin-converting enzyme 2 regulation of heart function	3/13	3.0198220634264697E-4	0.0056289483262269395	0	0	28.666666666666668	232.34741723598566	COL4A2;COL4A1;AGT
TSH regulation of gene expression	6/97	5.574416178877886E-4	0.009991068997527287	0	0	6.366839043309631	47.70133084700212	PPP1R15A;ADAMTS1;CAV1;PLK2;TIMP3;AGT
TGF-beta signaling pathway	8/185	7.728805320921795E-4	0.013339345479813173	0	0	4.388432063545338	31.444809987368867	KLF10;PPP1R15A;ZEB1;RPS6KB1;CAV1;AXIN1;DYNLRB1;ATF3
Acute myocardial infarction	3/20	0.0011401996126111852	0.018321828257821117	0	0	16.85677749360614	114.230828110504	COL4A2;COL4A1;F2R
Hypertrophy pathway	3/20	0.0011401996126111852	0.018321828257821117	0	0	16.85677749360614	114.230828110504	ZEB1;IFRD1;ATF3
Unfolded protein response	5/79	0.0014609849175557456	0.022693965719365914	0	0	6.498352010547133	42.42542991541516	TSPYL2;HSPA5;ATF3;HERPUD1;SEC31A
Smooth muscle contraction	3/22	0.0015166523627972346	0.02279870971172617	0	0	15.080854309687261	97.89359200664423	ACTA2;CALD1;ACTG2
Small leucine-rich proteoglycan (SLRP) molecules	2/6	0.0016008010222151178	0.023311664886007652	0	0	47.5625	306.17175716217304	BGN;DCN
Interleukin-1 regulation of extracellular matrix	6/120	0.0016891637307241498	0.02385303934901375	0	0	5.076367389060888	32.40510141777637	KDM6B;GREM1;COL1A2;PLK2;A2M;DCN
T cell receptor regulation of apoptosis	15/603	0.0018302277338417446	0.025084885999125086	0	0	2.512035583464155	15.834151260153567	CLIC5;HSPA5;PLK2;F2R;SLC3A2;F11R;CLU;TDP2;PERP;PMAIP1;STOM;VIM;ATF3;S100A10;CDKN3
Axon guidance	10/325	0.0023737828805320844	0.03160522349508432	0	0	3.0912698412698414	18.681379666819964	COL1A1;COL3A1;ABLIM1;COL1A2;COL4A2;COL4A1;COL5A2;COL6A3;CD24;VAV2
Transport of mature transcript to cytoplasm	4/55	0.0026508125629583373	0.03431329595384959	0	0	7.515324576432515	44.58758695024069	NXF1;CPSF1;SRSF5;SRSF6
S6K1 signaling	2/8	0.0029470308315396724	0.0368077040952209	0	0	31.705128205128204	184.74442232209134	RPS6KB1;EIF4B
PERK-regulated gene expression	3/28	0.0030804730895141953	0.0368077040952209	0	0	11.457971014492754	66.25768923135189	HSPA5;ATF3;HERPUD1
PKB-mediated events	3/28	0.0030804730895141953	0.0368077040952209	0	0	11.457971014492754	66.25768923135189	RPS6KB1;TSC1;EIF4B
Diabetes pathways	6/137	0.0032830820057658198	0.0382479053671718	0	0	4.413785361472834	25.242317817595747	TSPYL2;HSPA5;KIF5B;ATF3;SEC31A;HERPUD1
Integrin beta-2 pathway	3/29	0.0034095681485851073	0.038752652615625854	0	0	11.016722408026755	62.58786885861426	SPON2;THY1;F11R
p53 signaling pathway	6/139	0.003526028384266854	0.03912212445400843	0	0	4.346970367094206	24.549876577225486	GDF15;CAV1;PERP;PMAIP1;DKK1;ATF3
Tight junction interactions	3/30	0.003759377015205102	0.04074115556012971	0	0	10.608158883521202	59.23067658383079	CLDN10;PARD6B;F11R
Dermatan sulfate biosynthesis	2/10	0.004671210764967091	0.049472368556242374	0	0	23.776442307692307	127.59240152438093	BGN;DCN
Glycoprotein VI-mediated activation cascade	3/33	0.004936868515587409	0.05112401618363851	0	0	9.545893719806763	50.69847114861187	COL1A1;COL1A2;VAV2
Bone mineralization regulation	2/11	0.005669940781811908	0.05504567509009061	0	0	21.13354700854701	109.31489084599424	COL4A2;COL4A1
Vitamin C in the brain	2/11	0.005669940781811908	0.05504567509009061	0	0	21.13354700854701	109.31489084599424	COL4A2;COL4A1
Mammalian target of rapamycin complex 1 (mTORC1)-mediated signaling	2/11	0.005669940781811908	0.05504567509009061	0	0	21.13354700854701	109.31489084599424	RPS6KB1;EIF4B
FRA pathway	3/37	0.00681823892752944	0.06484284367813713	0	0	8.421142369991475	42.00595552158804	COL1A2;MGP;DCN
Striated muscle contraction	3/38	0.007346163929965753	0.06843967194051483	0	0	8.180124223602485	40.19367037551018	ACTA2;TNNT2;VIM
Leukocyte transendothelial migration	5/117	0.007893364905404791	0.06843967194051483	0	0	4.285278745644599	20.74817447910144	CLDN10;PECAM1;THY1;F11R;VAV2
E-cadherin nascent AJ-like junctions pathway	3/39	0.007897639685117683	0.06843967194051483	0	0	7.952495974235105	38.499554627432005	TJP1;VAV2;ARF6
Platelet adhesion to exposed collagen	2/13	0.007930777435166955	0.06843967194051483	0	0	17.289335664335663	83.62858941238636	COL1A1;COL1A2
Chondroitin sulfate/dermatan sulfate degradation	2/13	0.007930777435166955	0.06843967194051483	0	0	17.289335664335663	83.62858941238636	BGN;DCN
Interleukin-2 signaling pathway	17/847	0.008183524327887671	0.069336769759921	0	0	2.0121106186403646	9.669463929460704	TSPYL1;ST13;NOLC1;LITAF;PRSS23;GLS;PTP4A1;CEACAM1;ABLIM1;COL1A2;MAT2A;RPS6KB1;THRAP3;CTSK;PMAIP1;VIM;ARF6
Platelet amyloid precursor protein pathway	2/14	0.009189016238859454	0.07512423802295624	0	0	15.84775641025641	74.32195849793585	COL4A2;COL4A1
Adhesion and diapedesis of lymphocytes	2/14	0.009189016238859454	0.07512423802295624	0	0	15.84775641025641	74.32195849793585	PECAM1;CD34
Cleavage of growing transcript in the termination region	3/43	0.010343437965362372	0.08310417399756666	0	0	7.155797101449275	32.712032146257854	CPSF1;SRSF5;SRSF6
Coagulation intrinsic pathway	2/15	0.010529941116878461	0.08316868746551463	0	0	14.627958579881657	66.6088854573496	SERPING1;A2M
Wnt interactions in lipid metabolism and immune response	3/45	0.011712928687916081	0.08983047407900174	0	0	6.8143547273982055	30.3038581753277	KLF10;COL8A1;DKK1
Cell junction organization	4/84	0.011857720879952327	0.08983047407900174	0	0	4.783980582524272	21.215882618766496	CLDN10;PARD6B;CDH13;F11R
Inhibition of platelet activation by aspirin	2/16	0.011951693976176197	0.08983047407900174	0	0	13.582417582417582	60.1277633799834	F2R;F2RL3
Developmental biology	10/420	0.013604099153811807	0.10062714612184606	0	0	2.3634146341463413	10.15650052552226	COL1A1;COL3A1;ABLIM1;COL1A2;COL4A2;COL4A1;COL5A2;COL6A3;CD24;VAV2
Activation of chaperones by IRE1 alpha	3/48	0.013953877361580675	0.10160166953900929	0	0	6.359098228663446	27.166054038803594	TSPYL2;HSPA5;SEC31A
Thrombin signaling through protease-activated receptors	3/53	0.01819393471905394	0.12999175948056288	0	0	5.721739130434782	22.925103342999808	F2R;GNG11;F2RL3
Chondroitin sulfate biosynthesis	2/20	0.018410850055187018	0.12999175948056288	0	0	10.561965811965813	42.19310063010437	BGN;DCN
TAp63 pathway	3/55	0.02006845131378345	0.1395805718242252	0	0	5.501114827201784	21.50169197923541	GDF15;PERP;PMAIP1
Proximal tubule bicarbonate reclamation	2/23	0.024017176663778003	0.16021947546776336	0	0	9.051739926739927	33.75381155566142	AQP1;GLS
Signaling events mediated by PRL	2/23	0.024017176663778003	0.16021947546776336	0	0	9.051739926739927	33.75381155566142	PTP4A1;AGT
Interleukin-4 signaling pathway	4/104	0.024067303181852864	0.16021947546776336	0	0	3.8233009708737864	14.2490644949639	COL1A1;COL1A2;RPS6KB1;THY1
Phosphoinositides and their downstream targets	2/25	0.028092463989560897	0.18182066971021357	0	0	8.263795986622073	29.520377640639172	RPS6KB1;VAV2
Basigin interactions	2/25	0.028092463989560897	0.18182066971021357	0	0	8.263795986622073	29.520377640639172	CAV1;SLC3A2
Glycosaminoglycan metabolism	4/110	0.028804079533959904	0.18387261729897691	0	0	3.6057886059717896	12.790591269518542	BGN;PRELP;LYVE1;DCN
Epidermal growth factor receptor (EGFR) pathway	4/111	0.029643534777587948	0.18533684125353478	0	0	3.571908175301697	12.567799022545616	ACTA2;RPS6KB1;ACTG2;VAV2
Segmentation clock	2/26	0.030226609303151596	0.18533684125353478	0	0	7.919070512820513	27.70908620116636	AXIN1;DKK1
Tetrasaccharide linker sequence formation in glycosaminoglycan biosynthesis	2/26	0.030226609303151596	0.18533684125353478	0	0	7.919070512820513	27.70908620116636	BGN;DCN
Protein processing in the endoplasmic reticulum	5/166	0.03100435117249688	0.1876367226803058	0	0	2.9736403575215875	10.329319586924145	PPP1R15A;LMAN1;HSPA5;SEC31A;HERPUD1
Endochondral ossification	3/66	0.03220865322533526	0.19125470428472766	0	0	4.5380722337244075	15.590638505036305	ADAMTS1;MGP;TIMP3
Glucuronidation	2/27	0.03242300780792593	0.19125470428472766	0	0	7.601923076923077	26.066135142531248	UGDH;PGM3
Multi-step regulation of transcription by PITX2	2/28	0.03468013033505336	0.1999013336662727	0	0	7.309171597633136	24.57042622858587	AXIN1;DKK1
Messenger RNA splicing: major pathway	3/68	0.034746798341133235	0.1999013336662727	0	0	4.39799331103679	14.775796710864627	CPSF1;SRSF5;SRSF6
p53 activity regulation	4/118	0.03592394079893655	0.20415312697932234	0	0	3.3513881791858284	11.147894530960714	RRM2;PERP;PMAIP1;TIMP3
AP-1 transcription factor network	3/70	0.03738543595995673	0.20740015663499803	0	0	4.26627730910664	14.021009722959356	COL1A2;ATF3;AGT
Complement and coagulation cascades	3/70	0.03738543595995673	0.20740015663499803	0	0	4.26627730910664	14.021009722959356	F2R;SERPING1;A2M
Interleukin-6 signaling pathway	3/71	0.038742202617227633	0.21088136528551005	0	0	4.203324808184143	13.664276590203222	RPS6KB1;A2M;AGT
Inactivation of GSK3 by Akt causes accumulation of beta-catenin in alveolar macrophages	2/30	0.039370555321543724	0.21088136528551005	0	0	6.7864010989010985	21.952223199246387	AXIN1;DKK1
Nectin adhesion pathway	2/30	0.039370555321543724	0.21088136528551005	0	0	6.7864010989010985	21.952223199246387	F11R;VAV2
Signal transduction	17/1020	0.04077870387475848	0.2159417727913347	0	0	1.6498638798630016	5.278896711849018	F2R;FN1;AXIN1;F11R;GNG11;AGT;APLN;COL1A1;COL3A1;COL1A2;COL4A2;COL4A1;COL5A2;COL6A3;A2M;EIF4B;F2RL3
Myc repressed pathway	3/73	0.04153010017821857	0.21744973801179612	0	0	4.082815734989648	12.98881198271227	COL1A2;CLU;DKK1
RANKL regulation of apoptosis and immune response	3/74	0.042960999702619955	0.22244250957134334	0	0	4.025107164727495	12.668874094958563	CTSK;MGP;THBS2
Fibrin clot formation (clotting cascade)	2/32	0.0442861441799422	0.22431894769405505	0	0	6.333333333333333	19.741528347670254	SERPING1;A2M
Hypothetical network for drug addiction	2/32	0.0442861441799422	0.22431894769405505	0	0	6.333333333333333	19.741528347670254	NISCH;ZHX2
Cell-cell communication	4/129	0.0472322067302073	0.23656609178245325	0	0	3.054757281553398	9.325194237761062	CLDN10;PARD6B;CDH13;F11R
TOR signaling	2/34	0.0494155398450339	0.23656609178245325	0	0	5.936899038461538	17.855166463164597	RPS6KB1;TSC1
N-cadherin signaling events	2/34	0.0494155398450339	0.23656609178245325	0	0	5.936899038461538	17.855166463164597	KIF5B;AXIN1
Activation of NOXA and translocation to mitochondria	1/5	0.05141381038329779	0.23656609178245325	0	0	23.667464114832537	70.24144688058605	PMAIP1
Catalytic cycle of mammalian FMOs	1/5	0.05141381038329779	0.23656609178245325	0	0	23.667464114832537	70.24144688058605	FMO2
UDP-N-acetyl-glucosamine biosynthesis	1/5	0.05141381038329779	0.23656609178245325	0	0	23.667464114832537	70.24144688058605	PGM3
Electric transmission across gap junctions	1/5	0.05141381038329779	0.23656609178245325	0	0	23.667464114832537	70.24144688058605	PANX1
NOSTRIN-mediated endothelial NOS trafficking	1/5	0.05141381038329779	0.23656609178245325	0	0	23.667464114832537	70.24144688058605	CAV1
Cell adhesion molecules (CAMs)	4/133	0.051780560862253716	0.23656609178245325	0	0	2.959434033265598	8.762116119695909	CLDN10;PECAM1;F11R;CD34
Tight junction	4/133	0.051780560862253716	0.23656609178245325	0	0	2.959434033265598	8.762116119695909	TJP1;CLDN10;PARD6B;F11R
Transport to the Golgi and subsequent modification	2/36	0.054747757515563954	0.24769373788594953	0	0	5.58710407239819	16.230642757541354	LMAN1;SEC31A
Capped intron-containing pre-mRNA processing	4/138	0.05779084226165689	0.25538754552719034	0	0	2.848282857556876	8.120240675331889	NXF1;CPSF1;SRSF5;SRSF6
Small cell lung cancer	3/84	0.05859257140128656	0.25538754552719034	0	0	3.526391125424942	10.004891265941371	COL4A2;COL4A1;FN1
Biological oxidations	4/139	0.05903593305299534	0.25538754552719034	0	0	2.8270406328658755	7.999419577601055	UGDH;MAT2A;ADH1B;FMO2
Transport of mature mRNAs derived from intronless transcripts	2/38	0.06027217420539185	0.25538754552719034	0	0	5.276175213675214	14.82016803120891	NXF1;CPSF1
Asparagine N-linked glycosylation	3/85	0.06028461375105351	0.25538754552719034	0	0	3.4832096147048426	9.783215501194432	LMAN1;PGM3;SEC31A
C-Myb transcription factor network	3/85	0.06028461375105351	0.25538754552719034	0	0	3.4832096147048426	9.783215501194432	COL1A2;MAT2A;CD34
TGF-beta regulation of skeletal system development	3/85	0.06028461375105351	0.25538754552719034	0	0	3.4832096147048426	9.783215501194432	RPS6KB1;THBS2;DCN
Molybdenum cofactor biosynthesis	1/6	0.061376433673960354	0.25617049958166344	0	0	18.933014354066987	52.83691853686298	MOCS1
EGF/EGFR signaling pathway	4/141	0.061568875435936275	0.25617049958166344	0	0	2.7854864998937	7.764818838534064	RPS6KB1;CAV1;VAV2;ARF6
Aurora B signaling	2/39	0.06310323390714477	0.2588255916066044	0	0	5.133316008316008	14.18326620049302	CBX5;VIM
Messenger RNA processing	5/203	0.06331784859045687	0.2588255916066044	0	0	2.4134023158413402	6.659996121431171	RBM17;NXF1;CPSF1;SRSF5;SRSF6
Endothelial NOS activation	1/7	0.07123491846615712	0.2837219829506771	0	0	15.77671451355662	41.67848506599672	CAV1
Wnt/LRP6 signaling	1/7	0.07123491846615712	0.2837219829506771	0	0	15.77671451355662	41.67848506599672	DKK1
Inactivation of BCL-2 by BH3-only proteins	1/7	0.07123491846615712	0.2837219829506771	0	0	15.77671451355662	41.67848506599672	PMAIP1
BMP receptor signaling	2/42	0.07185686065110446	0.28377370392724305	0	0	4.747596153846154	12.500796612741404	PPP1R15A;GREM1
Insulin signaling pathway	6/277	0.07255083588152028	0.28410663462847435	0	0	2.1184067723030173	5.557571908392917	RPS6KB1;KIF5B;CAV1;TSC1;PYGL;ARF6
Fc gamma receptor-mediated phagocytosis	3/94	0.07651471915135004	0.29713215937107595	0	0	3.1372830068482243	8.06367113744584	RPS6KB1;VAV2;ARF6
Integrin signaling pathway	4/155	0.08086715849643217	0.3019320160367589	0	0	2.525429177650614	6.351321769421401	ACTA2;CAV1;NOLC1;ACTG2
Myometrial relaxation and contraction pathways	4/155	0.08086715849643217	0.3019320160367589	0	0	2.525429177650614	6.351321769421401	ACTA2;CALD1;GNG11;ATF3
Amino sugar and nucleotide sugar metabolism	2/45	0.08097596314776612	0.3019320160367589	0	0	4.415697674418604	11.09931056653905	UGDH;PGM3
Lysine catabolism	1/8	0.08099034764934519	0.3019320160367589	0	0	13.522214627477785	33.98707630579846	AASS
Oxygen/carbon dioxide exchange in erythrocytes	1/8	0.08099034764934519	0.3019320160367589	0	0	13.522214627477785	33.98707630579846	AQP1
Alpha-6 beta-1 and alpha-6 beta-4 integrin signaling	2/46	0.08409146992519352	0.3085561022451983	0	0	4.3151223776223775	10.683596363939206	RPS6KB1;PMP22
RhoA activity regulation	2/46	0.08409146992519352	0.3085561022451983	0	0	4.3151223776223775	10.683596363939206	FARP1;VAV2
Senescence and autophagy	3/99	0.08627591472490836	0.31288894491463265	0	0	2.9731280193236715	7.284772566620336	COL1A1;SPARC;FN1
RNA polymerase II transcription	3/101	0.09032145469806672	0.31288894491463265	0	0	2.912156166814552	7.001930781794919	CPSF1;SRSF5;SRSF6
Presenilin action in Notch and Wnt signaling	2/48	0.09042949994547218	0.31288894491463265	0	0	4.127090301003345	9.918160423663684	AXIN1;DKK1
Chondroitin sulfate/dermatan sulfate metabolism	2/48	0.09042949994547218	0.31288894491463265	0	0	4.127090301003345	9.918160423663684	BGN;DCN
Lipid digestion, mobilization, and transport	2/48	0.09042949994547218	0.31288894491463265	0	0	4.127090301003345	9.918160423663684	CAV1;A2M
Polyadenylation of mRNA	1/9	0.09064379305466826	0.31288894491463265	0	0	11.83133971291866	28.40489116599669	CPSF1
COPII-mediated vesicle transport	1/9	0.09064379305466826	0.31288894491463265	0	0	11.83133971291866	28.40489116599669	SEC31A
Inhibition of matrix metalloproteinases	1/9	0.09064379305466826	0.31288894491463265	0	0	11.83133971291866	28.40489116599669	TIMP3
Angiopoietin receptor Tie2-mediated signaling	2/49	0.09364985897326883	0.32088848736428877	0	0	4.039075286415712	9.565307218535958	RPS6KB1;FN1
MHC class II antigen presentation	3/103	0.0944449593313464	0.32125073757961625	0	0	2.853623188405797	6.733803232611758	KIF5B;CTSK;SEC31A
Wnt signaling pathway	5/231	0.09685810166132433	0.32424641005402804	0	0	2.111374919058925	4.929022148358085	F2R;AXIN1;TSC1;DKK1;DKK3
Aquaporin-mediated transport	2/50	0.09690303549603671	0.32424641005402804	0	0	3.9547275641025643	9.230509860987297	GNG11;AQP1
Malaria	2/51	0.10018799348821428	0.32424641005402804	0	0	3.8738226059654632	8.91253048793319	PECAM1;THBS2
Rheb GTPase activity by AMPK regulation	1/10	0.10019631555317604	0.32424641005402804	0	0	10.516214779372675	24.193854658645943	TSC1
COPI-mediated vesicle transport	1/10	0.10019631555317604	0.32424641005402804	0	0	10.516214779372675	24.193854658645943	COPG1
Ethanol oxidation	1/10	0.10019631555317604	0.32424641005402804	0	0	10.516214779372675	24.193854658645943	ADH1B
Interferon-alpha signaling pathway	1/10	0.10019631555317604	0.32424641005402804	0	0	10.516214779372675	24.193854658645943	ST13
Carbohydrate metabolism	5/235	0.10226601952436164	0.3275411392457373	0	0	2.0742311770943798	4.729615936352409	BGN;PRELP;PYGL;LYVE1;DCN
Apoptotic execution  phase	2/52	0.10350371485534247	0.3275411392457373	0	0	3.796153846153846	8.610237898188057	TJP1;VIM
Heparan sulfate/heparin glycosaminoglycan (HS-GAG) metabolism	2/52	0.10350371485534247	0.3275411392457373	0	0	3.796153846153846	8.610237898188057	BGN;DCN
Starch and sucrose metabolism	2/53	0.1068491991837155	0.3275411392457373	0	0	3.721530920060332	8.322596519156432	UGDH;PYGL
Signaling by insulin receptor	3/109	0.10726511817453599	0.3275411392457373	0	0	2.69127700300793	6.008146106524418	RPS6KB1;TSC1;EIF4B
Leptin influence on immune response	3/110	0.10946496177009789	0.3275411392457373	0	0	2.6659894351889477	5.897570567911453	COL1A1;CEACAM1;COL1A2
Passive transport by aquaporins	1/11	0.10964896506938845	0.3275411392457373	0	0	9.464114832535886	20.920153674500032	AQP1
Apoptotic cleavage of cell adhesion  proteins	1/11	0.10964896506938845	0.3275411392457373	0	0	9.464114832535886	20.920153674500032	TJP1
SUMOylation as a mechanism to modulate CtBP-dependent gene responses	1/11	0.10964896506938845	0.3275411392457373	0	0	9.464114832535886	20.920153674500032	ZEB1
Keratan sulfate degradation	1/11	0.10964896506938845	0.3275411392457373	0	0	9.464114832535886	20.920153674500032	PRELP
Methylation	1/11	0.10964896506938845	0.3275411392457373	0	0	9.464114832535886	20.920153674500032	MAT2A
Monocyte and its surface molecules	1/11	0.10964896506938845	0.3275411392457373	0	0	9.464114832535886	20.920153674500032	PECAM1
mTOR signaling pathway	3/113	0.11616806544791937	0.3423166407280126	0	0	2.5928853754940713	5.5817491953143215	RPS6KB1;TSC1;EIF4B
Platelet endothelial cell adhesion molecule 1 (PECAM1) interactions	1/12	0.11900278068227048	0.3423166407280126	0	0	8.603305785123966	18.313069126011605	PECAM1
Activation of chaperones by ATF6 alpha	1/12	0.11900278068227048	0.3423166407280126	0	0	8.603305785123966	18.313069126011605	HSPA5
Caspase-mediated cleavage of cytoskeletal proteins	1/12	0.11900278068227048	0.3423166407280126	0	0	8.603305785123966	18.313069126011605	VIM
Toll-like receptor endosomal trafficking and processing	1/12	0.11900278068227048	0.3423166407280126	0	0	8.603305785123966	18.313069126011605	CTSK
Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis	1/12	0.11900278068227048	0.3423166407280126	0	0	8.603305785123966	18.313069126011605	CAV1
Fas signaling pathway	3/115	0.12072074175644706	0.3451280101748732	0	0	2.5463250517598346	5.383632213899168	ACTA2;CUX1;ACTG2
Vascular smooth muscle contraction	3/116	0.12302154731724488	0.3495612259136348	0	0	2.523662947287418	5.288072633134219	ACTA2;CALD1;ACTG2
T helper cell surface molecules	1/13	0.1282587907765657	0.3622339181932098	0	0	7.885964912280702	16.195447567008262	THY1
DCC-mediated attractive signaling	1/14	0.13741801309765478	0.3665253917938827	0	0	7.278984173721016	14.446802304266713	ABLIM1
Glycogen breakdown (glycogenolysis)	1/14	0.13741801309765478	0.3665253917938827	0	0	7.278984173721016	14.446802304266713	PYGL
Hyaluronan metabolism	1/14	0.13741801309765478	0.3665253917938827	0	0	7.278984173721016	14.446802304266713	LYVE1
Interleukin-6 regulation of target genes	1/14	0.13741801309765478	0.3665253917938827	0	0	7.278984173721016	14.446802304266713	DCN
Intronless pre-mRNA processing	1/14	0.13741801309765478	0.3665253917938827	0	0	7.278984173721016	14.446802304266713	CPSF1
Osteoblast signaling	1/14	0.13741801309765478	0.3665253917938827	0	0	7.278984173721016	14.446802304266713	COL1A1
Peptide G-protein coupled receptors	4/192	0.14394982308646667	0.3665253917938827	0	0	2.0245816979962816	3.924227453312091	F2R;AGT;APLN;F2RL3
Factors involved in megakaryocyte development and platelet production	3/125	0.14441962386067358	0.3665253917938827	0	0	2.3364219529579473	4.521051624015585	CBX5;KIF5B;PHF21A
Endothelins	2/64	0.14534472320796957	0.3665253917938827	0	0	3.0595533498759306	5.9007982570230055	COL3A1;COL1A2
Adhesion and diapedesis of granulocytes	1/15	0.14648145489248263	0.3665253917938827	0	0	6.758714969241285	12.982521217388637	PECAM1
Arf6 vesicle-mediated transport	1/15	0.14648145489248263	0.3665253917938827	0	0	6.758714969241285	12.982521217388637	ARF6
Extrinsic prothrombin activation pathway	1/15	0.14648145489248263	0.3665253917938827	0	0	6.758714969241285	12.982521217388637	F2R
Fatty acid omega oxidation	1/15	0.14648145489248263	0.3665253917938827	0	0	6.758714969241285	12.982521217388637	ADH1B
Fibrinolysis pathway	1/15	0.14648145489248263	0.3665253917938827	0	0	6.758714969241285	12.982521217388637	F2R
HDL-mediated lipid transport	1/15	0.14648145489248263	0.3665253917938827	0	0	6.758714969241285	12.982521217388637	A2M
Interleukin-17 signaling pathway	1/15	0.14648145489248263	0.3665253917938827	0	0	6.758714969241285	12.982521217388637	CD34
PRC2 complex long-term gene silencing through modification of histone tails	1/15	0.14648145489248263	0.3665253917938827	0	0	6.758714969241285	12.982521217388637	EZH1
Spliceosome	3/127	0.14933302800082587	0.3665253917938827	0	0	2.2985039738195416	4.370780865663327	RBM17;SRSF5;SRSF6
Interleukin-4 regulation of apoptosis	5/267	0.15060877581326249	0.3665253917938827	0	0	1.8179110035375163	3.441432225334802	POSTN;UBL3;FN1;TIMP3;LITAF
Signaling by TGF-beta receptor complex	2/66	0.1526243950379091	0.3665253917938827	0	0	2.963641826923077	5.570980734747428	PPP1R15A;F11R
Amino acid biosynthesis and interconversion (transamination)	1/16	0.15545011293787353	0.3665253917938827	0	0	6.307814992025518	11.741558684376109	GLS
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)	1/16	0.15545011293787353	0.3665253917938827	0	0	6.307814992025518	11.741558684376109	F11R
Glutamate neurotransmitter release cycle	1/16	0.15545011293787353	0.3665253917938827	0	0	6.307814992025518	11.741558684376109	GLS
N-glycan precursor substrate biosynthesis	1/16	0.15545011293787353	0.3665253917938827	0	0	6.307814992025518	11.741558684376109	PGM3
cAMP cell motility pathway inferred from amoeba model	2/67	0.15629083604668204	0.3665253917938827	0	0	2.9178994082840237	5.4157283122724165	ACTA2;ACTG2
AMPK signaling	2/68	0.15997399042909047	0.3665253917938827	0	0	2.8735431235431235	5.266469024106059	RPS6KB1;TSC1
Epithelial cell signaling in Helicobacter pylori infection	2/68	0.15997399042909047	0.3665253917938827	0	0	2.8735431235431235	5.266469024106059	TJP1;F11R
Endocytosis	4/201	0.16158220406260013	0.3665253917938827	0	0	1.9312010250850131	3.5200797942844906	PARD6B;CAV1;F2R;ARF6
Phase I of biological oxidations: functionalization of compounds	2/69	0.1636731081937407	0.3665253917938827	0	0	2.830510907003444	5.122896637431133	ADH1B;FMO2
NFAT involvement in hypertrophy of the heart	2/69	0.1636731081937407	0.3665253917938827	0	0	2.830510907003444	5.122896637431133	RPS6KB1;AGT
ACE inhibitor pathway	1/17	0.16432497374812993	0.3665253917938827	0	0	5.913277511961723	10.678842642933322	AGT
Activation of BH3-only proteins	1/17	0.16432497374812993	0.3665253917938827	0	0	5.913277511961723	10.678842642933322	PMAIP1
Platelet sensitization by LDL	1/17	0.16432497374812993	0.3665253917938827	0	0	5.913277511961723	10.678842642933322	PECAM1
Renin-angiotensin system	1/17	0.16432497374812993	0.3665253917938827	0	0	5.913277511961723	10.678842642933322	AGT
Beta-catenin phosphorylation cascade	1/17	0.16432497374812993	0.3665253917938827	0	0	5.913277511961723	10.678842642933322	AXIN1
Cell to cell adhesion signaling	1/17	0.16432497374812993	0.3665253917938827	0	0	5.913277511961723	10.678842642933322	PECAM1
Energy-dependent regulation of mTOR by LKB1-AMPK	1/17	0.16432497374812993	0.3665253917938827	0	0	5.913277511961723	10.678842642933322	TSC1
G1/S-specific transcription	1/17	0.16432497374812993	0.3665253917938827	0	0	5.913277511961723	10.678842642933322	RRM2
GRB2-SOS provides linkage to MAPK signaling for integrins	1/17	0.16432497374812993	0.3665253917938827	0	0	5.913277511961723	10.678842642933322	FN1
Inflammasomes	1/17	0.16432497374812993	0.3665253917938827	0	0	5.913277511961723	10.678842642933322	PANX1
Integrin beta-5 pathway	1/17	0.16432497374812993	0.3665253917938827	0	0	5.913277511961723	10.678842642933322	FN1
Nitric oxide metabolism	1/17	0.16432497374812993	0.3665253917938827	0	0	5.913277511961723	10.678842642933322	CAV1
Osteoclast signaling	1/17	0.16432497374812993	0.3665253917938827	0	0	5.913277511961723	10.678842642933322	CTSK
Membrane trafficking	3/133	0.16438585168438088	0.3665253917938827	0	0	2.1917502787068006	3.9572903004482214	TJP1;COPG1;SEC31A
CDC42 signaling events	2/70	0.1673874530657261	0.3714407291839446	0	0	2.788744343891403	4.984724555721841	RPS6KB1;VAV2
Phase II of biological oxidations: conjugation	2/71	0.17111630244297796	0.3756525460168127	0	0	2.7481884057971016	4.85168430182746	UGDH;MAT2A
Bacterial invasion of epithelial cells	2/71	0.17111630244297796	0.3756525460168127	0	0	2.7481884057971016	4.85168430182746	CAV1;FN1
Gastrin-CREB signaling pathway via PKC and MAPK	4/206	0.17170384614073197	0.3756525460168127	0	0	1.8829183889262713	3.3176722835523953	F2R;GNG11;AGT;F2RL3
Nucleotide di- and triphosphate biosynthesis and interconversion	1/18	0.17310701358152283	0.37695265574294223	0	0	5.5651562060230795	9.76042305629853	RRM2
Signaling by FGFR1 fusion mutants	1/19	0.18179719863072918	0.3880840552296667	0	0	5.25571504518873	8.960276780734086	CUX1
Class C GPCRs (metabotropic glutamate and pheromone receptors)	1/19	0.18179719863072918	0.3880840552296667	0	0	5.25571504518873	8.960276780734086	GPRC5A
TP53 network	1/19	0.18179719863072918	0.3880840552296667	0	0	5.25571504518873	8.960276780734086	PMAIP1
Seven transmembrane receptor signaling through beta-arrestin	2/74	0.18238284998990772	0.3880840552296667	0	0	2.6332799145299144	4.480913472218032	ACTA2;ACTG2
E2F transcription factor network	2/74	0.18238284998990772	0.3880840552296667	0	0	2.6332799145299144	4.480913472218032	CBX5;RRM2
Prolactin activation of MAPK signaling	2/75	0.18616275488512132	0.3943265626203024	0	0	2.5970758693361433	4.366032444837357	RPS6KB1;VAV2
Signaling by Hippo	1/20	0.19039648505561949	0.3996610902518859	0	0	4.9788466381264165	8.258147136064768	TJP1
Skeletal muscle hypertrophy is regulated via AKT/mTOR pathway	1/20	0.19039648505561949	0.3996610902518859	0	0	4.9788466381264165	8.258147136064768	RPS6KB1
G alpha (12/13) signaling events	2/77	0.1937551821559524	0.4048875106936045	0	0	2.5275641025641025	4.1481367600665235	GNG11;VAV2
Presynaptic function of kainate receptors	1/21	0.19890581913727384	0.41195605207986496	0	0	4.729665071770335	7.6380488652036655	GNG11
Prion pathway	1/21	0.19890581913727384	0.41195605207986496	0	0	4.729665071770335	7.6380488652036655	HSPA5
ATM-dependent DNA damage response	2/82	0.21289724375447402	0.4313167328066949	0	0	2.3689903846153846	3.6646993783427644	AXIN1;PMAIP1
Platelet homeostasis	2/82	0.21289724375447402	0.4313167328066949	0	0	2.3689903846153846	3.6646993783427644	PECAM1;GNG11
SMAD2/3 nuclear pathway	2/82	0.21289724375447402	0.4313167328066949	0	0	2.3689903846153846	3.6646993783427644	COL1A2;ATF3
EGFR1 pathway	3/152	0.21464083839033887	0.4313167328066949	0	0	1.9104172745841843	2.9397294062781882	RRM2;CAV1;TIMP3
Post-elongation processing of intronless pre-mRNA	1/23	0.21565836640334746	0.4313167328066949	0	0	4.2992605480643755	6.595322606380214	CPSF1
Angiogenesis	1/23	0.21565836640334746	0.4313167328066949	0	0	4.2992605480643755	6.595322606380214	TIMP3
Deadenylation of mRNA	1/23	0.21565836640334746	0.4313167328066949	0	0	4.2992605480643755	6.595322606380214	EIF4B
Nitrogen metabolism	1/23	0.21565836640334746	0.4313167328066949	0	0	4.2992605480643755	6.595322606380214	GLS
Drug metabolism: cytochrome P450	2/83	0.2167484489547227	0.43164434706367855	0	0	2.339624881291548	3.577328133891295	ADH1B;FMO2
Plexin D1 signaling	1/24	0.22390342349675155	0.4340356381964719	0	0	4.112128146453089	6.153966169257627	ARF6
Protein export	1/24	0.22390342349675155	0.4340356381964719	0	0	4.112128146453089	6.153966169257627	HSPA5
SREBP signaling	1/24	0.22390342349675155	0.4340356381964719	0	0	4.112128146453089	6.153966169257627	SEC31A
Sulfur amino acid metabolism	1/24	0.22390342349675155	0.4340356381964719	0	0	4.112128146453089	6.153966169257627	MAT2A
Dorso-ventral axis formation	1/24	0.22390342349675155	0.4340356381964719	0	0	4.112128146453089	6.153966169257627	PIWIL4
Endogenous Toll-like receptor signaling	1/24	0.22390342349675155	0.4340356381964719	0	0	4.112128146453089	6.153966169257627	BGN
Myc active pathway	2/85	0.22446907468959168	0.4340356381964719	0	0	2.2830166821130677	3.4108664951255014	MYCT1;PMAIP1
Alpha-9 beta-1 integrin pathway	1/25	0.23206221632782834	0.44502466176447736	0	0	3.9405901116427433	5.756216097044229	FN1
C-Myc pathway	1/25	0.23206221632782834	0.44502466176447736	0	0	3.9405901116427433	5.756216097044229	AXIN1
Hematopoietic cell lineage	2/88	0.2360874217350885	0.44816302425038934	0	0	2.20304114490161	3.1802068994154	CD24;CD34
ALK1 pathway	1/26	0.24013564312088603	0.44816302425038934	0	0	3.782775119617225	5.39632289925392	CAV1
Physiological and pathological hypertrophy  of the heart	1/26	0.24013564312088603	0.44816302425038934	0	0	3.782775119617225	5.39632289925392	AGT
RXR/VDR pathway	1/26	0.24013564312088603	0.44816302425038934	0	0	3.782775119617225	5.39632289925392	RPS6KB1
Ascorbate and aldarate metabolism	1/26	0.24013564312088603	0.44816302425038934	0	0	3.782775119617225	5.39632289925392	UGDH
Selenoamino acid metabolism	1/26	0.24013564312088603	0.44816302425038934	0	0	3.782775119617225	5.39632289925392	MAT2A
Neural crest differentiation	2/91	0.2477382190953848	0.44816302425038934	0	0	2.128457216940363	2.9700122898465886	AXIN1;PMP22
ADP signalling through P2Y purinoceptor 12	1/27	0.24812459282532284	0.44816302425038934	0	0	3.6370997423629	5.069477888036122	GNG11
CTCF pathway	1/27	0.24812459282532284	0.44816302425038934	0	0	3.6370997423629	5.069477888036122	RPS6KB1
TWEAK regulation of gene expression	1/27	0.24812459282532284	0.44816302425038934	0	0	3.6370997423629	5.069477888036122	COL1A1
VEGFR1 pathway	1/27	0.24812459282532284	0.44816302425038934	0	0	3.6370997423629	5.069477888036122	CAV1
eIF4E and p70 S6 kinase regulation	1/27	0.24812459282532284	0.44816302425038934	0	0	3.6370997423629	5.069477888036122	RPS6KB1
FSH signaling pathway	1/27	0.24812459282532284	0.44816302425038934	0	0	3.6370997423629	5.069477888036122	RPS6KB1
Glycosphingolipid biosynthesis: lacto and neolacto series	1/27	0.24812459282532284	0.44816302425038934	0	0	3.6370997423629	5.069477888036122	ABO
Kinesins	1/27	0.24812459282532284	0.44816302425038934	0	0	3.6370997423629	5.069477888036122	KIF5B
Metabolism	20/1615	0.2521631386456332	0.45369892899175707	0	0	1.200791948523346	1.6543058812897469	RRM2;TGDS;ADH1B;CAV1;BGN;FMO2;GNG11;LYVE1;ABO;AGT;DCN;AQP1;GLS;UGDH;MAT2A;KDSR;A2M;MOCS1;AASS;PAFAH1B2
TGF-beta receptor activation of SMADs	1/28	0.25602994516831923	0.4553815055283846	0	0	3.5022151337940812	4.771631071215738	PPP1R15A
G-protein activation	1/28	0.25602994516831923	0.4553815055283846	0	0	3.5022151337940812	4.771631071215738	GNG11
G-protein beta-gamma signalling	1/28	0.25602994516831923	0.4553815055283846	0	0	3.5022151337940812	4.771631071215738	GNG11
L1CAM interactions	2/94	0.25940822471428543	0.4570828922129385	0	0	2.05873745819398	2.7779621261974095	CD24;VAV2
Pentose and glucuronate interconversions	1/29	0.2638525708267821	0.4570828922129385	0	0	3.3769651401230347	4.499349401337084	UGDH
Adherens junction actin cytoskeletal organization	1/29	0.2638525708267821	0.4570828922129385	0	0	3.3769651401230347	4.499349401337084	CDH13
IGF1 pathway	1/29	0.2638525708267821	0.4570828922129385	0	0	3.3769651401230347	4.499349401337084	RPS6KB1
Inhibition of insulin secretion by adrenaline/noradrenaline	1/29	0.2638525708267821	0.4570828922129385	0	0	3.3769651401230347	4.499349401337084	GNG11
Lipoprotein metabolism	1/29	0.2638525708267821	0.4570828922129385	0	0	3.3769651401230347	4.499349401337084	A2M
Matrix metalloproteinases	1/29	0.2638525708267821	0.4570828922129385	0	0	3.3769651401230347	4.499349401337084	TIMP3
Activation of kainate receptors upon glutamate binding	1/30	0.27159333139843245	0.460227245206071	0	0	3.2603530770499916	4.249705381475953	GNG11
Apoptosis intrinsic pathway	1/30	0.27159333139843245	0.460227245206071	0	0	3.2603530770499916	4.249705381475953	PMAIP1
Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein	1/30	0.27159333139843245	0.460227245206071	0	0	3.2603530770499916	4.249705381475953	PGM3
CDC42 activity regulation	1/30	0.27159333139843245	0.460227245206071	0	0	3.2603530770499916	4.249705381475953	VAV2
Signaling by FGFR1 mutants	1/30	0.27159333139843245	0.460227245206071	0	0	3.2603530770499916	4.249705381475953	CUX1
Gap junction trafficking and regulation	1/30	0.27159333139843245	0.460227245206071	0	0	3.2603530770499916	4.249705381475953	TJP1
Prostaglandin biosynthesis and regulation	1/31	0.27925307951025297	0.46310297171451204	0	0	3.1515151515151514	4.020188744958083	S100A10
Amino acid transport across the plasma membrane	1/31	0.27925307951025297	0.46310297171451204	0	0	3.1515151515151514	4.020188744958083	SLC3A2
Signal amplification	1/31	0.27925307951025297	0.46310297171451204	0	0	3.1515151515151514	4.020188744958083	GNG11
CD40/CD40L signaling	1/31	0.27925307951025297	0.46310297171451204	0	0	3.1515151515151514	4.020188744958083	TDP2
Stathmin and breast cancer resistance to antimicrotubule agents	1/31	0.27925307951025297	0.46310297171451204	0	0	3.1515151515151514	4.020188744958083	HSPA5
Keratan sulfate/keratin metabolism	1/31	0.27925307951025297	0.46310297171451204	0	0	3.1515151515151514	4.020188744958083	PRELP
Integrin-mediated cell adhesion	2/100	0.2827567896449933	0.4672505814700953	0	0	1.9321036106750393	2.4405717461767877	CAV1;VAV2
TNF-alpha signaling pathway	2/101	0.2866443721958138	0.46735671006932233	0	0	1.9124902874902876	2.3896813863940687	CAV1;PYGL
Alanine, aspartate and glutamate metabolism	1/32	0.2868326589695841	0.46735671006932233	0	0	3.0496990276277205	3.808635853107745	GLS
Sphingolipid de novo biosynthesis	1/32	0.2868326589695841	0.46735671006932233	0	0	3.0496990276277205	3.808635853107745	KDSR
Syndecan 4 pathway	1/32	0.2868326589695841	0.46735671006932233	0	0	3.0496990276277205	3.808635853107745	FN1
Syndecan 2 pathway	1/33	0.29433290492971276	0.4713372292001586	0	0	2.9542464114832536	3.6131728238618512	FN1
E2F-mediated regulation of DNA replication	1/33	0.29433290492971276	0.4713372292001586	0	0	2.9542464114832536	3.6131728238618512	RRM2
Fluoropyrimidine activity	1/33	0.29433290492971276	0.4713372292001586	0	0	2.9542464114832536	3.6131728238618512	RRM2
Glucagon signaling in metabolic regulation	1/33	0.29433290492971276	0.4713372292001586	0	0	2.9542464114832536	3.6131728238618512	GNG11
Glucagon-type ligand receptors	1/33	0.29433290492971276	0.4713372292001586	0	0	2.9542464114832536	3.6131728238618512	GNG11
Transcription	3/181	0.29613110623593614	0.472592792828583	0	0	1.5968083374043316	1.9432406906384583	CPSF1;SRSF5;SRSF6
Cysteine and methionine metabolism	1/34	0.30175464378659994	0.47346014816348675	0	0	2.8645788023778453	3.432169395669736	MAT2A
EGF receptor transactivation by GPCRs in cardiac hypertrophy	1/34	0.30175464378659994	0.47346014816348675	0	0	2.8645788023778453	3.432169395669736	AGT
Ephrin receptor A forward pathway	1/34	0.30175464378659994	0.47346014816348675	0	0	2.8645788023778453	3.432169395669736	VAV2
Interleukin-7 interactions in immune response	1/34	0.30175464378659994	0.47346014816348675	0	0	2.8645788023778453	3.432169395669736	LITAF
Monoamine transport	1/34	0.30175464378659994	0.47346014816348675	0	0	2.8645788023778453	3.432169395669736	AGT
Prion diseases	1/35	0.3090986933881511	0.47695361297641864	0	0	2.780185758513932	3.2642012445450987	HSPA5
Arf6 signal transduction regulation	1/35	0.3090986933881511	0.47695361297641864	0	0	2.780185758513932	3.2642012445450987	ARF6
Signal transduction by L1	1/35	0.3090986933881511	0.47695361297641864	0	0	2.780185758513932	3.2642012445450987	VAV2
Ether lipid metabolism	1/35	0.3090986933881511	0.47695361297641864	0	0	2.780185758513932	3.2642012445450987	PAFAH1B2
Interleukin-2/PI3K pathway	1/35	0.3090986933881511	0.47695361297641864	0	0	2.780185758513932	3.2642012445450987	RPS6KB1
Glycogen metabolism	1/36	0.31636586315752563	0.48495556655068073	0	0	2.7006151742993847	3.1080190158619745	PYGL
Neurotransmitter release cycle	1/36	0.31636586315752563	0.48495556655068073	0	0	2.7006151742993847	3.1080190158619745	GLS
ALK in cardiac myocytes	1/37	0.3235569540648964	0.4927370607654958	0	0	2.625465178096757	2.9625227250436295	AXIN1
Platelet aggregation (plug formation)	1/37	0.3235569540648964	0.4927370607654958	0	0	2.625465178096757	2.9625227250436295	FN1
RAC1 activity regulation	1/38	0.3306727587309287	0.5019332428945041	0	0	2.554377343851028	2.8267404769100506	VAV2
Amino acid metabolism	3/195	0.33629003447568884	0.5076604927421707	0	0	1.4793176328502415	1.6121326834480103	MAT2A;AASS;GLS
Angiotensin II-mediated activation of JNK pathway via Pyk2-dependent signaling	1/39	0.3377140616954355	0.5076604927421707	0	0	2.4870309745656005	2.6998106824747663	AGT
G13 signaling pathway	1/39	0.3377140616954355	0.5076604927421707	0	0	2.4870309745656005	2.6998106824747663	RPS6KB1
Post-translational protein modification	3/196	0.33915946935957264	0.5081939315805815	0	0	1.47157768266126	1.5911946849396146	LMAN1;PGM3;SEC31A
G alpha (i) signaling events	3/199	0.3477628501933847	0.5170705463009291	0	0	1.4488317065956817	1.5303060280887455	GNG11;AGT;APLN
Alpha-M beta-2 integrin signaling	1/41	0.35157625972018125	0.5170705463009291	0	0	2.36244019138756	2.4695263832622665	THY1
Bioactive peptide-induced signaling pathway	1/41	0.35157625972018125	0.5170705463009291	0	0	2.36244019138756	2.4695263832622665	AGT
Tyrosine metabolism	1/41	0.35157625972018125	0.5170705463009291	0	0	2.36244019138756	2.4695263832622665	ADH1B
Insulin biosynthesis and processing	1/41	0.35157625972018125	0.5170705463009291	0	0	2.36244019138756	2.4695263832622665	KIF5B
Prolactin regulation of apoptosis	2/118	0.352114406863773	0.5170705463009291	0	0	1.6308023872679045	1.7022301239456226	SRRM2;HSPA5
Signaling events mediated by T cell protein tyrosine phosphatase (TC-PTP)	1/42	0.3583986833802577	0.5170705463009291	0	0	2.304702999183102	2.364877115497894	LMAN1
Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling	1/42	0.3583986833802577	0.5170705463009291	0	0	2.304702999183102	2.364877115497894	FN1
VEGF, hypoxia, and angiogenesis	1/42	0.3583986833802577	0.5170705463009291	0	0	2.304702999183102	2.364877115497894	CAV1
Fatty acid metabolism	1/42	0.3583986833802577	0.5170705463009291	0	0	2.304702999183102	2.364877115497894	ADH1B
Messenger RNA splicing: minor pathway	1/42	0.3583986833802577	0.5170705463009291	0	0	2.304702999183102	2.364877115497894	SRSF6
Netrin-1 signaling	1/42	0.3583986833802577	0.5170705463009291	0	0	2.304702999183102	2.364877115497894	ABLIM1
Insulin secretion regulation by glucagon-like peptide-1	1/43	0.3651496626520159	0.5235684393718136	0	0	2.249715197083618	2.266471019128794	GNG11
PI3K class IB pathway in neutrophils	1/43	0.3651496626520159	0.5235684393718136	0	0	2.249715197083618	2.266471019128794	ARF6
Rho GTPase cycle	2/123	0.3710155966198272	0.5298860949592796	0	0	1.56301652892562	1.5497483595968589	A2M;VAV2
Lysine degradation	1/44	0.37182994217099663	0.5298860949592796	0	0	2.197284967174808	2.1738150499785323	AASS
p75 neurotrophin receptor-mediated signaling	2/124	0.3747702196916809	0.5324479340741564	0	0	1.550126103404792	1.5213591550774677	ZNF274;VAV2
Signaling by FGFR mutants	1/45	0.378440258847894	0.5327890049036816	0	0	2.14723792953458	2.0864647728555634	CUX1
G alpha (z) signaling events	1/45	0.378440258847894	0.5327890049036816	0	0	2.14723792953458	2.0864647728555634	GNG11
Integrin-linked kinase signaling	1/45	0.378440258847894	0.5327890049036816	0	0	2.14723792953458	2.0864647728555634	ZEB1
ABC transporters	1/47	0.3914539129907596	0.5412982891801008	0	0	2.0536717287289368	1.9261130219838907	ABCA8
Actions of nitric oxide in the heart	1/47	0.3914539129907596	0.5412982891801008	0	0	2.0536717287289368	1.9261130219838907	CAV1
Regulation of NFAT transcription factors	1/47	0.3914539129907596	0.5412982891801008	0	0	2.0536717287289368	1.9261130219838907	SLC3A2
Delta Np63 pathway	1/47	0.3914539129907596	0.5412982891801008	0	0	2.0536717287289368	1.9261130219838907	PERP
LKB1 signaling events	1/47	0.3914539129907596	0.5412982891801008	0	0	2.0536717287289368	1.9261130219838907	TSC1
Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways	1/47	0.3914539129907596	0.5412982891801008	0	0	2.0536717287289368	1.9261130219838907	PANX1
PDGFB signaling pathway	2/129	0.39340267276993146	0.5423835665999647	0	0	1.4887189582071472	1.3888580412135696	ACTA2;VAV2
Post-translational regulation of adherens junction stability and disassembly	1/48	0.3978586863377555	0.5453004348041002	0	0	2.0098747836709765	1.8524179696792191	ARF6
Diurnally regulated genes with circadian orthologs	1/48	0.3978586863377555	0.5453004348041002	0	0	2.0098747836709765	1.8524179696792191	HERPUD1
Amino acid and oligopeptide SLC transporters	1/49	0.40419636883981463	0.5459579938531989	0	0	1.967902711323764	1.7826334432267585	SLC3A2
Arf6 integrin-mediated signaling pathway	1/49	0.40419636883981463	0.5459579938531989	0	0	1.967902711323764	1.7826334432267585	ARF6
Deadenylation-dependent mRNA decay	1/49	0.40419636883981463	0.5459579938531989	0	0	1.967902711323764	1.7826334432267585	EIF4B
G alpha 12 pathway	1/49	0.40419636883981463	0.5459579938531989	0	0	1.967902711323764	1.7826334432267585	VAV2
Interleukin-5 signaling pathway	1/49	0.40419636883981463	0.5459579938531989	0	0	1.967902711323764	1.7826334432267585	RPS6KB1
Translation factors	1/50	0.41046765980788213	0.5528263857528124	0	0	1.927643784786642	1.716486090768287	EIF4B
TNF-alpha effects on cytokine activity, cell motility, and apoptosis	2/135	0.4154250701095762	0.5547706720510291	0	0	1.421124927703875	1.2483914811692192	PMAIP1;OPTN
Type I interferon (interferon-alpha/beta) pathway	1/51	0.4166732515404726	0.5547706720510291	0	0	1.8889952153110048	1.6537264031435053	PTP4A1
Glutathione metabolism	1/51	0.4166732515404726	0.5547706720510291	0	0	1.8889952153110048	1.6537264031435053	RRM2
Metabolism of vitamins and cofactors	1/51	0.4166732515404726	0.5547706720510291	0	0	1.8889952153110048	1.6537264031435053	MOCS1
Signaling events mediated by PTP1B	1/52	0.42281382900059405	0.5565854359160363	0	0	1.8518622760108827	1.5941262277727029	CAV1
Signaling events mediated by stem cell factor receptor (c-Kit)	1/52	0.42281382900059405	0.5565854359160363	0	0	1.8518622760108827	1.5941262277727029	RPS6KB1
Endometrial cancer	1/52	0.42281382900059405	0.5565854359160363	0	0	1.8518622760108827	1.5941262277727029	AXIN1
Interleukin-2 receptor beta chain in T cell activation	1/52	0.42281382900059405	0.5565854359160363	0	0	1.8518622760108827	1.5941262277727029	RPS6KB1
Actin cytoskeleton regulation	3/226	0.42427884114971165	0.5569406759880722	0	0	1.271657893026581	1.0902742009694368	F2R;FN1;VAV2
PI3K pathway	1/53	0.4288900701436193	0.5614122828284455	0	0	1.8161575266838426	1.5374765805356705	RPS6KB1
GPCR ligand binding	5/410	0.43142623399092533	0.5629573137318761	0	0	1.1674194519722976	0.9814013603924127	F2R;GNG11;AGT;F2RL3;APLN
RANKL signaling pathway	1/54	0.43490264580144933	0.5629573137318761	0	0	1.7818001263880112	1.483585719510534	CTSK
Arginine and proline metabolism	1/54	0.43490264580144933	0.5629573137318761	0	0	1.7818001263880112	1.483585719510534	GLS
Kit receptor signaling pathway	1/54	0.43490264580144933	0.5629573137318761	0	0	1.7818001263880112	1.483585719510534	RPS6KB1
Basal cell carcinoma	1/55	0.4408522199091409	0.565942519222203	0	0	1.748715222399433	1.4322774420056963	AXIN1
Vibrio cholerae infection	1/55	0.4408522199091409	0.565942519222203	0	0	1.748715222399433	1.4322774420056963	TJP1
Meiotic synapsis	1/55	0.4408522199091409	0.565942519222203	0	0	1.748715222399433	1.4322774420056963	SYNE1
Pathways in cancer	4/325	0.4455684530110215	0.5704255469866374	0	0	1.1776910746151288	0.9520506342281904	COL4A2;COL4A1;FN1;AXIN1
Interleukin-5 regulation of apoptosis	2/144	0.447689985831661	0.5715713243768603	0	0	1.3304442036836404	1.0692171812767943	CEACAM1;CD24
Activation of mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S	1/57	0.4525649847255455	0.5746465473626818	0	0	1.6860902255639099	1.336772651146228	EIF4B
Acute myeloid leukemia	1/57	0.4525649847255455	0.5746465473626818	0	0	1.6860902255639099	1.336772651146228	RPS6KB1
Nucleotide excision repair	1/58	0.4583294690704551	0.5803845994207393	0	0	1.656425753378662	1.292288692025391	CUL4A
ATF2 transcription factor network	1/59	0.46403353934467473	0.5844314306341039	0	0	1.6277841940273883	1.2498101750822759	ATF3
Caspase cascade in apoptosis	1/59	0.46403353934467473	0.5844314306341039	0	0	1.6277841940273883	1.2498101750822759	VIM
Apoptosis	3/242	0.4682106731530021	0.5867824846460064	0	0	1.1855557576860105	0.8996434891880546	TJP1;PMAIP1;VIM
RAGE pathway	1/60	0.46967782569304806	0.5867824846460064	0	0	1.6001135349931068	1.2092190738543465	FN1
Natural killer cell receptor signaling pathway	1/60	0.46967782569304806	0.5867824846460064	0	0	1.6001135349931068	1.2092190738543465	VAV2
Glucose metabolism	1/61	0.4752629517562245	0.5905934280490683	0	0	1.5733652312599682	1.1704060133321716	PYGL
Leptin signaling pathway	1/61	0.4752629517562245	0.5905934280490683	0	0	1.5733652312599682	1.1704060133321716	RPS6KB1
Colorectal cancer	1/62	0.48078953457150836	0.5958721359317098	0	0	1.5474939210918504	1.1332695112819784	AXIN1
Validated nuclear estrogen receptor alpha network	1/64	0.4916695074023424	0.6077400277174841	0	0	1.4982152350573403	1.0636556904567147	CALCOCO1
Retinol metabolism	1/65	0.49702409993228414	0.611116703346819	0	0	1.474730861244019	1.031009066380347	ADH1B
ERK1/ERK2 MAPK pathway	1/65	0.49702409993228414	0.611116703346819	0	0	1.474730861244019	1.031009066380347	RPS6KB1
Retinoblastoma protein regulation	1/66	0.5023225544482497	0.6133489058992082	0	0	1.451969083548031	0.9996993382683725	BRD2
Thyroid-stimulating hormone signaling pathway	1/66	0.5023225544482497	0.6133489058992082	0	0	1.451969083548031	0.9996993382683725	RPS6KB1
Antigen presentation: folding, assembly, and peptide loading of class I MHC proteins	3/255	0.5027881589130849	0.6133489058992082	0	0	1.1236484932137105	0.7726053693179776	HSPA5;UBR4;SEC31A
Telomerase regulation	1/67	0.507565456752351	0.6175600596516856	0	0	1.4298970566913152	0.9696555156075702	RPS6KB1
Signaling events mediated by VEGFR1 and VEGFR2	1/70	0.5229666172050892	0.6313534808745378	0	0	1.367519589487553	0.8864776800818699	CAV1
MicroRNA regulation of DNA damage response	1/70	0.5229666172050892	0.6313534808745378	0	0	1.367519589487553	0.8864776800818699	PMAIP1
Nucleotide metabolism	1/70	0.5229666172050892	0.6313534808745378	0	0	1.367519589487553	0.8864776800818699	RRM2
Rac1 cell motility signaling pathway	1/71	0.5279930476047592	0.6325058102411768	0	0	1.3479152426520848	0.8608759432657642	RPS6KB1
Viral myocarditis	1/71	0.5279930476047592	0.6325058102411768	0	0	1.3479152426520848	0.8608759432657642	CAV1
Mitochondrial pathway of apoptosis: multidomain Bcl-2 family	1/71	0.5279930476047592	0.6325058102411768	0	0	1.3479152426520848	0.8608759432657642	UBL3
Sphingolipid metabolism	1/72	0.5329667646931693	0.6368269547359408	0	0	1.3288631309387424	0.836248534476841	KDSR
Cap-dependent translation initiation	1/73	0.5378883185356725	0.6394284603000596	0	0	1.3103402445507708	0.8125476551400207	EIF4B
Degradation of beta-catenin by the destruction complex	1/73	0.5378883185356725	0.6394284603000596	0	0	1.3103402445507708	0.8125476551400207	AXIN1
Adherens junction cell adhesion	1/74	0.5427582537060012	0.6435759445979556	0	0	1.2923248345021958	0.7897284155065997	TJP1
Glycolysis and gluconeogenesis	1/75	0.5475771090111176	0.6476419614192406	0	0	1.2747963274279064	0.7677486235489359	ADH1B
Disease	7/674	0.5652475878032832	0.6618169766500521	0	0	0.988626376466939	0.5640028805054542	TSPYL2;CUX1;HSPA5;KIF5B;ATF3;SEC31A;HERPUD1
Signaling events mediated by hepatocyte growth factor receptor (c-Met)	1/79	0.5663523134810141	0.6618169766500521	0	0	1.2091767881241566	0.6874640802603651	ARF6
p73 transcription factor network	1/79	0.5663523134810141	0.6618169766500521	0	0	1.2091767881241566	0.6874640802603651	GDF15
Fc epsilon receptor I signaling pathway	1/79	0.5663523134810141	0.6618169766500521	0	0	1.2091767881241566	0.6874640802603651	VAV2
Apoptosis modulation and signaling	1/80	0.5709236579685	0.6618169766500521	0	0	1.193810187147962	0.6691303437888109	PMAIP1
Cardiac muscle contraction	1/80	0.5709236579685	0.6618169766500521	0	0	1.193810187147962	0.6691303437888109	TNNT2
Nuclear beta-catenin signaling and target gene transcription regulation	1/80	0.5709236579685	0.6618169766500521	0	0	1.193810187147962	0.6691303437888109	DKK1
Opioid signaling	1/80	0.5709236579685	0.6618169766500521	0	0	1.193810187147962	0.6691303437888109	GNG11
Neuronal system	3/283	0.5731107636634721	0.6621193102986151	0	0	1.0098343685300206	0.5621508357768922	PANX1;GNG11;GLS
Antigen processing and presentation	1/81	0.575447040066393	0.6621193102986151	0	0	1.1788277511961722	0.6514297393739676	HSPA5
MAP kinase signaling pathway	1/81	0.575447040066393	0.6621193102986151	0	0	1.1788277511961722	0.6514297393739676	RPS6KB1
T cell signal transduction	1/83	0.5843519149712164	0.6690614063306802	0	0	1.1499591550939432	0.6178177220361486	VAV2
Meiosis	1/83	0.5843519149712164	0.6690614063306802	0	0	1.1499591550939432	0.6178177220361486	SYNE1
Chemokine signaling pathway	2/189	0.5924667573869337	0.6757237930984207	0	0	1.0079699712052652	0.5276324784403743	GNG11;VAV2
MicroRNAs in cardiomyocyte hypertrophy	1/85	0.5930708827838069	0.6757237930984207	0	0	1.1224652540442015	0.5864222678241484	AGT
Transmission across chemical synapses	2/190	0.5953447264732576	0.6766601037476537	0	0	1.0025572831423895	0.5199409135342218	GNG11;GLS
Non-class A, B, C GPCRs	1/86	0.5973618618707845	0.6773007971576291	0	0	1.1092034900084435	0.5714973715169794	F2R
Androgen receptor signaling, proteolysis, and transcription regulation	1/88	0.605809187129361	0.6852113621414617	0	0	1.083594566353187	0.5430869939212062	CAV1
Gap junction pathway	1/90	0.6140801135258028	0.692190271922694	0	0	1.059136605558841	0.5164666572400998	TJP1
Adaptive immune system	6/606	0.6149501557424792	0.692190271922694	0	0	0.9406862745098039	0.45737489462843606	HSPA5;CTSK;KIF5B;UBR4;CD34;SEC31A
ERBB signaling pathway	1/94	0.6301073592314251	0.706814483955646	0	0	1.0133765498790965	0.46804322368426177	RPS6KB1
Class B GPCRs (secretin family receptors)	1/95	0.6340095585696567	0.706814483955646	0	0	1.0025450473378805	0.4568510038480165	GNG11
Transport of inorganic cations/anions and amino acids/oligopeptides	1/95	0.6340095585696567	0.706814483955646	0	0	1.0025450473378805	0.4568510038480165	SLC3A2
G-protein signaling pathways	1/95	0.6340095585696567	0.706814483955646	0	0	1.0025450473378805	0.4568510038480165	GNG11
Mitochondrial pathway of apoptosis: BH3-only Bcl-2 family	1/97	0.6416914673939559	0.7136711785336121	0	0	0.9815590111642744	0.4354663694397534	CTSK
Wnt signaling pathway and pluripotency	1/98	0.6454720288549858	0.7161665843962461	0	0	0.9713905194100528	0.4252489325076393	AXIN1
Pyrimidine metabolism	1/100	0.6529144622374555	0.7209908516650575	0	0	0.9516698081291383	0.405705547236673	RRM2
Dilated cardiomyopathy	1/100	0.6529144622374555	0.7209908516650575	0	0	0.9516698081291383	0.405705547236673	TNNT2
Chromosome maintenance	1/103	0.6637875485618187	0.7312647698104197	0	0	0.9235387935078337	0.37845985996823267	SYNE1
Transmembrane transport of small molecules	4/432	0.6678810187973266	0.7340390442442316	0	0	0.8784139370293077	0.35456760169336377	SLC3A2;ABCA8;GNG11;AQP1
Fibroblast growth factor receptor pathway	1/105	0.6708472554909635	0.7355642848442093	0	0	0.9056864188443136	0.3615625214453035	RPS6KB1
ERBB1 downstream pathway	1/106	0.6743215852465134	0.737638166020834	0	0	0.897015265436318	0.3534672080323572	VAV2
Cytoplasmic ribosomal proteins	1/108	0.68116112566261	0.7433749052898743	0	0	0.88015919152171	0.33794275395050155	RPS6KB1
Protein metabolism	4/442	0.685263593267696	0.7461047534176316	0	0	0.857915502948087	0.32425062884331873	LMAN1;PGM3;EIF4B;SEC31A
Lipid metabolism regulation by peroxisome proliferator-activated receptor alpha (PPAR-alpha)	1/112	0.6944142779833612	0.7543054861078003	0	0	0.8482693219535324	0.3093524160868332	AGT
Immunoregulatory interactions between a lymphoid and a non-lymphoid cell	1/119	0.7163013735567488	0.776270790877779	0	0	0.7976644229989458	0.2661441549524702	CD34
G alpha s pathway	1/120	0.7192980242073863	0.7777096967068261	0	0	0.7909211531502554	0.26059231314983544	PYGL
Lysosome	1/121	0.7222631707722306	0.7791079573607858	0	0	0.7842902711323764	0.2551811562462209	CTSK
G alpha (s) signaling events	1/125	0.7338152577336063	0.7879214518522132	0	0	0.7588362401605186	0.23485827931333497	GNG11
Integration of energy metabolism	1/125	0.7338152577336063	0.7879214518522132	0	0	0.7588362401605186	0.23485827931333497	GNG11
Neurotrophin signaling pathway	1/126	0.7366277603017197	0.7891230719554055	0	0	0.7527272727272727	0.23008809396679045	ZNF274
Signaling by FGFR in disease	1/128	0.7421643439496413	0.7932306978911303	0	0	0.7407979504954225	0.22089452020462083	CUX1
Class A GPCRs (rhodopsin-like)	2/253	0.746922077484716	0.7964889888052119	0	0	0.7485059760956175	0.21840986209637492	F2R;F2RL3
Adipogenesis	1/133	0.7555042332536338	0.8038013075255557	0	0	0.7125561838480499	0.19977930176113312	AGT
Lipid and lipoprotein metabolism	4/489	0.7583416663653185	0.8049822699914315	0	0	0.7728956060454409	0.21379934689538407	CAV1;KDSR;A2M;AGT
Mitotic G1-G1/S phases	1/135	0.7606457961829464	0.805593047775575	0	0	0.7018496036563594	0.1920172606833935	RRM2
Ubiquitin-mediated proteolysis	1/136	0.7631760788178775	0.8064400288642425	0	0	0.696615275562644	0.18827177418910215	CUL4A
Natural killer cell-mediated cytotoxicity	1/137	0.765679738971656	0.8072551094135558	0	0	0.6914579228820715	0.18461324419740158	VAV2
T cell receptor signaling pathway	1/139	0.7706083039756648	0.810617312985688	0	0	0.6813674502461687	0.1775473716302969	VAV2
Toll-like receptor signaling pathway regulation	1/142	0.7778083580501316	0.8163484118273904	0	0	0.6667684685601819	0.16754232132267824	CTSK
Neuroactive ligand-receptor interaction	2/272	0.7819672321343224	0.8188690565721218	0	0	0.6951566951566952	0.1709685351491072	F2R;F2RL3
Calcium regulation in the cardiac cell	1/149	0.7937457312471188	0.8293397102268101	0	0	0.6350058192163456	0.1466813319768058	GNG11
Translation	1/151	0.7980865748940502	0.8320097178984953	0	0	0.6264752791068581	0.14129410527490385	EIF4B
Integrated breast cancer pathway	1/152	0.8002227774957262	0.832374585520108	0	0	0.6222947495167781	0.13868779291292133	TSC1
Phagosome	1/154	0.8044279355195914	0.8348851179334734	0	0	0.614097632673484	0.1336423176846214	THBS2
Toll receptor cascades	1/159	0.8145593856480978	0.843521497137808	0	0	0.5945127490763733	0.12193928707505773	CTSK
Purine metabolism	1/164	0.8241683486823221	0.8515797128291842	0	0	0.5761293920803123	0.11141216875381982	RRM2
Fatty acid, triacylglycerol, and ketone body metabolism	1/173	0.8402325558378719	0.866085928962652	0	0	0.5457327250472905	0.09499928269934879	AGT
Metapathway biotransformation	1/174	0.8419247335194879	0.866085928962652	0	0	0.5425505434632298	0.09335377417244259	FMO2
Calcium signaling pathway	1/178	0.8485169211114169	0.8709446811407935	0	0	0.5301813856675587	0.08709037898832465	F2R
Innate immune system	2/319	0.8509796282320327	0.8715527621013784	0	0	0.5906636738655666	0.0953136778175952	PANX1;CTSK
Jak-STAT signaling pathway	1/199	0.8788903465920654	0.8981642577015405	0	0	0.47344255956696146	0.06111913208087404	PTP4A1
Phospholipid metabolism	1/205	0.8863962801986166	0.9038526620843661	0	0	0.4593770522563092	0.055396811390652105	KDSR
Antigen-activated B-cell receptor generation of second messengers	1/211	0.8934390926065446	0.9090450156215062	0	0	0.44611528822055135	0.0502669831462266	VAV2
Signaling by NGF	1/221	0.904224426752802	0.9161090392789932	0	0	0.4256198347107438	0.04285042165725736	VAV2
Immune system	7/998	0.9043136439234698	0.9161090392789932	0	0	0.6541285361355649	0.06579161203815154	PANX1;HSPA5;CTSK;KIF5B;UBR4;CD34;SEC31A
SLC-mediated transmembrane transport	1/251	0.9304840236295839	0.9405760412394493	0	0	0.37397129186602873	0.026944770961470212	SLC3A2
Gene expression	6/968	0.9441351445716644	0.952309474827696	0	0	0.5756389874036932	0.03309116064519829	NXF1;ZNF274;CPSF1;SRSF5;SRSF6;EIF4B
Signaling by GPCR	6/977	0.9472262083498006	0.9533637431771211	0	0	0.5700308959835222	0.030905562287997002	F2R;GNG11;AGT;VAV2;F2RL3;APLN
Cell cycle	2/453	0.9530435689418688	0.9571515153597218	0	0	0.41231025072488486	0.01982992078732298	RRM2;SYNE1
MAPK signaling pathway	1/314	0.9645888418601174	0.9666632264662682	0	0	0.29773606249140133	0.01073437920790892	HSPA5
Generic transcription pathway	1/377	0.9820002426068806	0.9820002426068806	0	0	0.24704774508805863	0.004487306951322905	ZNF274
